Bernard H. Munos, M.B.A. (2016)
Bernard H. Munos founded the InnoThink Center for Research in Biomedical Innovation, a consultancy that focuses on pharmaceutical innovation. He previously served as an advisor for corporate strategy at Eli Lilly and Company, where he focused on disruptive innovation and the radical redesign of research and development.
Several of Munos’ research papers — published in Nature and Science — have helped stimulate a broad rethinking of the pharmaceutical business model by industry, investors, policymakers, regulators and patient advocates. His work has been profiled by Forbes magazine, and FiercePharma named him one of the 25 most influential people in biopharmaceuticals today.
Munos received his master’s degree in business administration from Stanford University and holds graduate degrees in agricultural economics and animal science from the University of California, Davis, and the Paris Institute of Technology for Life, Food and Environmental Sciences.
Social Media Links